Use of cookies by
Norton Rose Fulbright
We use cookies to deliver our online services. Details and instructions on how to disable those cookies are set out at nortonrosefulbright.com/cookies-policy. By continuing to use this website you agree to our use of our cookies unless you have disabled them.

Richard Fogl

Partner

Richard Fogl

Sydney

T:+61 2 9330 8464

Richard Fogl is a corporate and commercial lawyer based in Sydney.  He leads the life sciences and healthcare group in Australia and specialises in mergers and acquisitions.

Richard provides corporate advisory services to a broad range of clients including listed public companies, subsidiaries of overseas multi-nationals and other Australian businesses. 

His extensive transactional experience is the result of more than 30 years’ practice in Australia, Hong Kong and London.

 

[+Open all]
  • Education
    • Bachelor of Commerce, University of NSW (1981)
    • Bachelor of Laws, University of NSW (1983)
  • Representative experience
    • Acted for Medibank Private Limited (ASX 50 company) in relation to various outsourced healthcare services transactions and issues including telephone nurse triage and other government health services initiatives.
    • Acted for Medibank Private Limited on the sale of its travel and workplace health businesses.
    • Represented Bayer on the Australian aspects of the global disposal of its diabetes division.
    • Represented Zimmer on the Australian aspects of its global merger with Biomet, Inc.
    • Acted for Zimmer Biomet on several M&A transactions.
    • Advised various healthcare companies on privacy and health records regulations.
    • Acted for Thorn Group Limited (ASX listed) on its acquisition of Cash Resources Australia Pty Ltd.
    • Acted for Thorn Group Limited on the sale of its credit management business to Credit Corp Limited.
    • Acted for the vendors on the sale of 100 per cent of the shares in Heyday5 to Southern Cross Electrics (ASX listed)
    • Day to day legal adviser on a broad range of commercial contracts, issues and transactions for a diverse range of companies.
  • Admissions
    • England and Wales 1990
    • New South Wales 1984
    • Hong Kong 1990
  • Memberships and activities
    • AusBiotech
  • Languages
    • English